Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mucosal vaccines — fortifying the frontiers
Ed C. Lavelle, Ross W. Ward
Nature reviews. Immunology (2021) Vol. 22, Iss. 4, pp. 236-250
Open Access | Times Cited: 485

Showing 1-25 of 485 citing articles:

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2127-2135
Open Access | Times Cited: 533
Monkeypox: disease epidemiology, host immunity and clinical interventions
Fok‐Moon Lum, Anthony Torres‐Ruesta, Matthew Zirui Tay, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 597-613
Open Access | Times Cited: 379
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 208
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors
Laura Pérez‐Alós, José Juan Almagro Armenteros, Johannes Roth Madsen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 162
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 141
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
Cell Host & Microbe (2023) Vol. 31, Iss. 1, pp. 146-157
Open Access | Times Cited: 126
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
Jingxin Li, Shipo Wu, Xiling Guo, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 8, pp. 739-748
Open Access | Times Cited: 117
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
Meera Madhavan, Adam Ritchie, Jeremy Aboagye, et al.
EBioMedicine (2022) Vol. 85, pp. 104298-104298
Open Access | Times Cited: 106
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
Sara Terreri, Eva Piano Mortari, M. Vinci, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 400-408.e4
Open Access | Times Cited: 99
New-age vaccine adjuvants, their development, and future perspective
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 82
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans
Mangalakumari Jeyanathan, Dominik Fritz, Sam Afkhami, et al.
JCI Insight (2022) Vol. 7, Iss. 3
Open Access | Times Cited: 72
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 68
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 65
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
Van‐An Duong, Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 207-207
Open Access | Times Cited: 57
Principles and therapeutic applications of adaptive immunity
Hongbo Chi, Marion Pepper, Paul G. Thomas
Cell (2024) Vol. 187, Iss. 9, pp. 2052-2078
Open Access | Times Cited: 55
The Promise and Potential of Metal–Organic Frameworks and Covalent Organic Frameworks in Vaccine Nanotechnology
Yalini H. Wijesundara, Thomas S. Howlett, Sneha Kumari, et al.
Chemical Reviews (2024) Vol. 124, Iss. 6, pp. 3013-3036
Closed Access | Times Cited: 23
Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 18
The durability of vaccine-induced protection: an overview
Vipin M. Vashishtha, Puneet Kumar
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 389-408
Open Access | Times Cited: 18
An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission
Julia M. Adler, Ricardo Martin Vidal, Christine Langner, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Mucosal immune response in biology, disease prevention and treatment
Xiaoxue Zhou, Yuchen Wu, Zhipeng Zhu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Overview of mucosal immunity and respiratory infections in children: a focus on Africa
Richard K. Mwape, Mikhail Barday, Marieke M. van der Zalm, et al.
Current Opinion in Pediatrics (2025)
Closed Access | Times Cited: 1
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection
P.A. van der Ley, Afshin Zariri, Elly van Riet, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 87
The role of B cells in COVID-19 infection and vaccination
Shiru Chen, Fei Guan, Fabio Candotti, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top